Sunshine Biopharma
SBFM
5 hedge funds and large institutions have $89.6K invested in Sunshine Biopharma in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
50% more capital inflows, than outflows
Capital inflows: $505K | Capital outflows: $336K
22.28% less ownership
Funds ownership: 22.28% → 0% (-22%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$181K |
| 2 |
HRT Financial
New York
|
+$105K |
| 3 |
XTX Topco
George Town,
Cayman Islands
|
+$105K |
| 4 |
Jane Street
New York
|
+$66.7K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$47.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$279K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$33.3K |
| 3 |
Bridgeway Capital Management
Houston,
Texas
|
-$17.3K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.22K |
SBFM Hedge Fund Activity: Q2 2024 in Review
5 of the 6,944 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q2 2024, worth a combined $89.6K — down 74% from $346K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SBFM positions and 3 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $181K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $279K sold.
- 5 institutional investors held Sunshine Biopharma (SBFM) as of Q2 2024, up from 3 in Q1 2024.
- Funds reported $89.6K of Sunshine Biopharma stock for Q2 2024, down 74% quarter-over-quarter.
- 5 funds opened new Sunshine Biopharma positions in Q2 2024 and 3 closed out, a net change of +2 holders.
- The largest Sunshine Biopharma buyer in Q2 2024 was Susquehanna International Group, an estimated $181K added.
- The largest Sunshine Biopharma seller in Q2 2024 was Renaissance Technologies, an estimated $279K sold.
Based on aggregated 13F filings for Q2 2024.